Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the Neuraminidase-Specific inhibitor 4-guanidino-Neu5Ac2en

Virology

Volumn 214, Issue 2, 1995, Pages 475-484

  Blick, Tony J ^a   Tiong, Tak ^a   Sahasrabudhe, Anjali ^a   Varghese, Joseph N ^a   Colman, Peter M ^a   Hart, Graham J ^b   Bethell, Richard C ^b   McKimm Breschkin, Jennifer L ^a  

^a BIOMOLECULAR RESEARCH INSTITUTE   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029585928     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1995.0058     Document Type: Article

References (30)

1. Baker, A. T., Varghese, J. N., Laver, W. G., Air, G. M., and Colman, P. M. (1987). Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2, 111-117.
2. Bean, W. J., Threlkeld, S. C., and Webster, R. G. (1989). Biologic potential of amantadine-resistant influenza A virus in an avian model. J. Infect. Dis. 159, 1050-1056.
3. Brunger, A. T. (1992). "X-PLOR, Version 3.3: A System for X-ray Crystallography and NMR." Yale Univ. Press, New Haven, CT.
4. Burmeister, W. P., Ruigrok, R. W. H., and Cusack, S. (1992). The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 11, 49-56.
5. Dixon, M. (1953). The determination of enzyme inhibitor constants. Bio-chem. J. 55, 170-171.
6. Engh, R. A., and Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. Sect. A 47, 392-400.
7. Grambas, S., Bennett, M. S., and Hay, A. J. (1992). Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses. Virology 191, 541-549.
8. Hart, G. J., and Bethell, R. C. (1995). 2, 3-Didehydro-2, 4-dideoxy-4-gua-nidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow binding inhibitor of sialidase from both influenza A virus and influenza B virus. Biochem. Mol. Biol. Int. 36, 695-703.
9. Hay, A. J., Wostenholme, A. J., Skehel, J. J., and Smith, M. H. (1985). The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4, 3021-3024.
10. Hayden, F. G., Sperber, S. J., Belshe, R. B., Clover, R. D., Hay, A. J., and Pyke, S. (1991). Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother. 35, 1741-1747.
11. Jones, T. A., Zou, J. Y., and Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and location of errors in these models. Acta Crystallogr. Sect. A 47, 110-119.
12. Kendal, A. P., and Klenk, H. D. (1991). Amantadine inhibits an early M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses. Arch. Virol. 119, 265-273.
13. Laver, W. G., Colman, P. M., Webster, R. G., Hinshaw, V. S., and Air, G. M. (1984). Influenza virus neuraminidase with hemagglutinin activity. Virology 137, 314-323.
14. Luzzatti, P. V. (1952). Traitment statistique des erreurs dans la determination des structures cristallines. Acta Crystallogr. 5, 802-810.
15. Mast, E. E., Davis, J. P., Harmon, M. W., Arden, N. H., Circo, R., and Tyszka, G. E. (1991). Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am. J. Epidemiol. 134, 988-997.
16. McKimm-Breschkin, J. L. (1990). The use of tetramethylbenzidine for solid phase immunoassays. J. Immunol. Methods 135, 277-280.
17. Mc Kimm-Breschkin, J. L., Blick, T. J., Sahasrabudhe, A. V., Tiong, T., Marshall, D., Hart, G. J., Bethell B, and Penn, C. R. (1996). Generation and characterization of variants of the NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5-Ac2en. Antimicrob. Agents Chemother. 40, in press.
18. Mc Kimm-Breschkin, J. L., Caldwell, J. B., Guthrie, R. E., and Kortt, A. A. (1991). A new method for the purification of the influenza A virus neuraminidase. J. Virol. Methods 32, 121-124.
19. Mc Kimm-Breschkin, J. L., Marshall, D., and Penn, C. R. (1994). Phenotypic changes observed in influenza viruses passaged in 4-amino-Neu5Ac2en or 4-guanidino-Neu5Ac2en in vitro. Abstracts Ninth International Conference on Negative Strand Viruses, Estoril, Portugal., p. 171.
20. Meindl, P., and Tuppy, H. (1969). 2-Deoxy-2, 3-dehydrosialic acids. I. Synthesis and properties of 2-deoxy-2, 3-dehydro-N-acylneuraminic acids and their methyl esters. Monstah. Chem. 100, 1295-1306.
21. Morrison, J. F., and Walsh, C. T. (1988). The behavior and significance of slow binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61, 201-301.
22. Palese, P., and Schulman. (1977). Inhibitors of viral neuraminidase as potential antiviral drugs. In "Chemoprophylaxis and Virus Infections of the Upper Respiratory Tract" (J. S. Oxford, Ed.), Vol. 1, pp. 189-205, CRC, Cleveland.
23. Potier, M., Mameli, L., Belislem, M., Dallaire, L., and Melanxon, S. B. (1979). Fluorometric assay of neuraminidase with a sodium (4-meth-ylumbelliferyl-a-D-N-acetylneuraminate) substrate. Anal. Biochem. 94, 287-296.
24. Tulip, W. R., Varghese, J. N., Baker, A. T., van Donkelaar, A., Laver, W. G., Webster, R. G., and Colman, P. M. (1991). Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J. Mol. Biol. 221, 487-497.
25. Varghese, J. N., and Colman, P. M. (1991). Three dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J. Mol. Biol. 221, 473-486.
26. Varghese, J. N., Laver, W. G., and Colman, P. M. (1983). Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303, 35-40.
27. Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A., and Colman, P. M. (1992). The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327-332.
28. Varghese, J. N., Epa, V. C., and Colman, P. M. (1995). The three dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4, 1081-1087
29. von Itzstein, M., Wu, W. Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Phan, T. V., Smythe, M. L., White, H. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M., and Penn, C. R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
30. Woods, J. M., Bethell, R. C., Coates, J. A. V., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, M., Ticehurst, J., Tilling, J., Walcott, S. M., and Penn, C. R. (1993). 4-Guanidino-2, 4-dideoxy-2, 3-dehyro-N-acetylneur-aminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37, 1473-1479.